When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Peptide: BPC 157 & TB 500 in The Colony TX Early evidence suggests BPC 157 repairs tissue rather than just dulling symptoms. To read more, tap the link in bio.